Business
Announcement on the Completion of National (Excluding Hong Kong, Macao, and Taiwan) Market Access for the Company’s 9-Valent HPV Vaccine
Announcement on the Completion of National (Excluding Hong Kong, Macao, and Taiwan) Market Access for the Company’s 9-Valent HPV Vaccine
About this update from Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A
Announcement on the Completion of National (Excluding Hong Kong, Macao, and Taiwan) Market Access for the Company’s 9-Valent HPV Vaccine The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment